ClinicalTrials.Veeva

Menu

An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream Infections

M

Methodist Health System

Status

Active, not recruiting

Conditions

Bacterial Infections

Study type

Observational

Funder types

Other

Identifiers

NCT06211829
016.PHA.2022.D

Details and patient eligibility

About

In July 2020, a bundle (Appendix C) was implemented at Methodist Dallas Medical Center where all patients with SAB were reviewed by the antimicrobial stewardship pharmacist (Monday - Friday from 0700 to 1500), a note outlining optimal interventions was written in the electronic medical record (EMR), and the recommendations were communicated to the primary team via secure messaging or telephone

Full description

Evaluation of the Staphylococcus aureus bloodstream infection(SAB)bundle recommendations will allow for determination of whether this intervention is impactful and warrants the resources currently devoted to it.

Enrollment

208 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age SAB during hospital admission

Exclusion criteria

  • Patients with a history of a prior SAB during the study period (only first occurrence included)
  • Blood culture collected within 48hours of patient expiring or transitioning to hospice
  • Patients discharged or left before culture results were available
  • Patients transferred from an outside hospital

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems